Forte Biosciences
FBRX
58 hedge funds and large institutions have $74.7M invested in Forte Biosciences in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 5 closing their positions.
73% more call options, than puts
Call options by funds: $653K | Put options by funds: $377K
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
14% more capital invested
Capital invested by funds: $65.6M → $74.7M (+$9.09M)
2% more funds holding
Funds holding: 57 → 58 (+1)
0% less ownership
Funds ownership: 0.09% → 0.08% (-0%)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$630K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$519K |
| 3 |
Millennium Management
New York
|
+$421K |
| 4 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
+$329K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$292K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSAG
Lake Street Advisors Group
Portsmouth,
New Hampshire
|
-$648K |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$644K |
| 3 |
CI
CPMG Inc
Dallas,
Texas
|
-$556K |
| 4 |
JP Morgan Chase
New York
|
-$528K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$384K |
FBRX Hedge Fund Activity: Q1 2018 in Review
58 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2018, worth a combined $74.7M — up 14% from $65.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FBRX positions and 5 closed out — a net gain of 1 holder — while 16 added to existing stakes and 18 trimmed.
The largest buyer was State Street, adding an estimated $630K. The largest seller was Lake Street Advisors Group, cutting an estimated $648K.
- 58 institutional investors held Forte Biosciences (FBRX) as of Q1 2018, up from 57 in Q4 2017.
- Funds reported $74.7M of Forte Biosciences stock for Q1 2018, up 14% quarter-over-quarter.
- 6 funds opened new Forte Biosciences positions in Q1 2018 and 5 closed out, a net change of +1 holder.
- The largest Forte Biosciences buyer in Q1 2018 was State Street, an estimated $630K added.
- The largest Forte Biosciences seller in Q1 2018 was Lake Street Advisors Group, an estimated $648K sold.
Based on aggregated 13F filings for Q1 2018.